House Propose Bills Companies, scientists, and patient-advocacy groups all applaud the ultimate objective of recently introduced legislation designed to get effective drugs to patients more quickly. However, not everyone agrees that the current versions of the Senate and House bills to reform the Food and Drug Administration are the way to accomplish the goal.
DISSENTER: Edward Kennedy (D-Mass.) voted against the Senate bill.
REVISIONIST: Nancy Kassabaum (R-Kan.) sponsor of the Senate FDA reform bill.